Consistent with the requirement of histone chaperones for the establishment of an epigenetic landscape permissive for tumorigenesis upon SETD2 loss, SETD2-deficient cancer cells were more sensitive to genetic and chemical inhibition of histone chaperones. This evidence concerns the gene SETD2 and cancer.